Press releases

As previously communicated, Pharmacolog i Uppsala AB (“Pharmacolog” or “the Company”) has carried out a directed new issue of shares ...

• Regulatory
• Tuesday 28 July 2020

Pharmacolog AB has signed an agreement with Capstone Health Alliance to enter a long-term cooperation with sales in the ...

• Non regulatory
• Wednesday 8 July 2020

Tidigare har styrelsen i Pharmacolog i Uppsala AB (publ) (“Pharmacolog” eller “Bolaget”) meddelat beslutet att vederlagsfritt dela ut teckningsoptioner till ...

• Regulatory
• Thursday 2 July 2020

Pharmacolog AB has signed a letter of intent with HiperScan GmbH to enter mutual collaboration regarding sales in selected markets. ...

• Regulatory
• Wednesday 1 July 2020

INFORMATIONEN I DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, TILL AUSTRALIEN, HONG KONG, JAPAN, ...

• Regulatory
• Tuesday 30 June 2020

INFORMATIONEN I DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, TILL AUSTRALIEN, HONG KONG, JAPAN, ...

• Regulatory
• Monday 29 June 2020

Pharmacolog is today launching a brand-new software for WasteLog®. The software is designed to provide a quick and effective ...

• Non regulatory
• Wednesday 24 June 2020

Pharmacolog has today approved DrugLog® software version 4.5 for official release. The software has undergone extensive development and includes ...

• Non regulatory
• Wednesday 17 June 2020

The shareholders of Pharmacolog in Uppsala AB (publ) held the Extraordinary General Meeting on June 16, 2020 in Uppsala. (information ...

• Regulatory
• Tuesday 16 June 2020

The shareholders of Pharmacolog in Uppsala AB (publ), corporate identity number 556723-6418 (the “Company”), are hereby invited to attend ...

• Regulatory
• Friday 29 May 2020